<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03039998</url>
  </required_header>
  <id_info>
    <org_study_id>NT14382</org_study_id>
    <nct_id>NCT03039998</nct_id>
  </id_info>
  <brief_title>Validity of Biological Material Sampling in Patients With Hospital-acquired Pneumonia</brief_title>
  <official_title>Validity of Biological Material Sampling in Patients With Hospital-acquired Pneumonia</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital Olomouc</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Palacky University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University Hospital Olomouc</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The main objective of project is to compare validity of sampling methods performed routinely
      (bronchial secretion, stomach content, oropharyngeal smear) for determination of etiological
      agent responsible for hospital-acquired pneumonia (HAP) in critically ill patients to
      bronchoscopy-assisted protected brush method. Evaluation of the present clinical praxis using
      bronchial secretion sampling in HAP diagnostics and detection of the most common etiological
      agents in patients with HAP are other priorities of the project. Aiming to confirm or exclude
      the diagnosis of HAP, determine the sources and possible routes of bacterial pathogens
      transmission molecular biology analysis of etiological agents is performed. Finally,
      percentage of HAP etiological agents resistant to initial empiric antibiotic therapy will be
      observed.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The main objective of project will be comparing validity of sampling methods performed
      routinely (bronchial secretion, stomach content, oropharyngeal smear) for determination of
      etiological agent responsible for hospital-acquired pneumonia (HAP) in critically ill
      patients to bronchoscopy-assisted protected brush method. Obtained results of different
      methods will enable to determine if the bronchial secretion sample, stomach content sample or
      oropharyngeal smear are comparable to precise but technically difficult protected brush.
      Evaluation of the present clinical praxis using bronchial secretion sampling in HAP
      diagnostics and detection of the most common etiological agents in patients with HAP will be
      other priorities of the project. The role of atypical and fungal pathogens in HAP initiation
      will be discovered as well. Aiming to confirm or exclude the diagnosis of HAP, determine the
      sources and possible routes of bacterial pathogens transmission molecular biology analysis of
      etiological agents will be performed. Finally, percentage of HAP etiological agents resistant
      to initial empiric antibiotic therapy will be observed.

      Project fulfills program objectives of molecular-biologic approaches and research support in
      infectious diseases domain. It will make contribution to faster and more precise HAP
      diagnosis and adequate antibiotic therapy.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>March 2013</start_date>
  <completion_date type="Actual">December 2015</completion_date>
  <primary_completion_date type="Actual">December 2014</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Sensitivity and specificity of diagnostic methods etiological agents HAP. Scale: sensitivity and specificity of each method.</measure>
    <time_frame>72 hours</time_frame>
    <description>Obtaining 4 types of agent samples: endotracheal aspirate, gastric aspirate, oropharyngeal swab and protected specimen brushing when clinical signs of HAP arisen and after 72 hours</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">56</enrollment>
  <condition>Hospital Acquired Pneumonia</condition>
  <arm_group>
    <arm_group_label>HAP Patients</arm_group_label>
    <description>HAP, intubated and mechanically ventilated.</description>
  </arm_group>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      endotracheal aspirate, gastric aspirate, oropharyngeal swab, protected specimen brushing
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        The patients hospitalized in the Department of Anesthesiology and Intensive Care Medicine,
        Faculty of Medicine and Dentistry, Palacky University Olomouc and University Hospital
        Olomouc fulfilling HAP criteria will be enrolled in the study: presence of newly developed
        or progressive infiltrates on chest radiographs after minimum of 48hours of hospitalization
        plus at least two other signs of respiratory tract infection: temperature &gt;38 °C, purulent
        sputum, leukocytosis &gt;10x103/mm3 or leukopenia &lt;4x103/mm3, signs of inflammation on
        auscultation, cough and/or respiratory insufficiency with oxygenation index (Horowitz)
        PaO2/ FiO2 ≤300 mm Hg. Clinically ongoing lung inflammation is verified by chest radiograph
        or CT in the mechanically ventilated patient.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  clinical signs of HAP

          -  need for intubation and mechanical ventilation

        Exclusion Criteria:

          -  inability to obtain samples in 24 hours after clinical diagnosis of HAP
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Tomáš Gabrhelík, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital Olomouc</affiliation>
  </overall_official>
  <reference>
    <citation>Vincent JL, Bihari DJ, Suter PM, Bruining HA, White J, Nicolas-Chanoin MH, Wolff M, Spencer RC, Hemmer M. The prevalence of nosocomial infection in intensive care units in Europe. Results of the European Prevalence of Infection in Intensive Care (EPIC) Study. EPIC International Advisory Committee. JAMA. 1995 Aug 23-30;274(8):639-44.</citation>
    <PMID>7637145</PMID>
  </reference>
  <reference>
    <citation>Uvizl R, Hanulik V, Husickova V, Sedlakova MH, Adamus M, Kolar M. Hospital-acquired pneumonia in ICU patients. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2011 Dec;155(4):373-8. doi: 10.5507/bp.2011.067.</citation>
    <PMID>22336651</PMID>
  </reference>
  <reference>
    <citation>American Thoracic Society; Infectious Diseases Society of America. Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med. 2005 Feb 15;171(4):388-416.</citation>
    <PMID>15699079</PMID>
  </reference>
  <reference>
    <citation>Craven DE, Palladino R, McQuillen DP. Healthcare-associated pneumonia in adults: management principles to improve outcomes. Infect Dis Clin North Am. 2004 Dec;18(4):939-62. Review.</citation>
    <PMID>15555833</PMID>
  </reference>
  <reference>
    <citation>Uvizl R, Adamus M, Cerny V, Dusek L, Jarkovsky J, Sramek V, Matejovic M, Stourac P, Kula R, Malaska J, Sevcik P. Patient survival, predictive factors and disease course of severe sepsis in Czech intensive care units: A multicentre, retrospective, observational study. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2016 Jun;160(2):287-97. doi: 10.5507/bp.2015.052. Epub 2015 Oct 23.</citation>
    <PMID>26526190</PMID>
  </reference>
  <reference>
    <citation>Jones RN. Microbial etiologies of hospital-acquired bacterial pneumonia and ventilator-associated bacterial pneumonia. Clin Infect Dis. 2010 Aug 1;51 Suppl 1:S81-7. doi: 10.1086/653053. Review. Erratum in: Clin Infect Dis. 2010 Nov 1;51(9):1114.</citation>
    <PMID>20597676</PMID>
  </reference>
  <reference>
    <citation>[Pneumonia-causing bacterial pathogens in intensive care patients]. Klin Mikrobiol Infekc Lek. 2011 Aug;17(4):135-40. Czech.</citation>
    <PMID>22052100</PMID>
  </reference>
  <reference>
    <citation>Torres A, Ewig S, Lode H, Carlet J; European HAP working group. Defining, treating and preventing hospital acquired pneumonia: European perspective. Intensive Care Med. 2009 Jan;35(1):9-29. doi: 10.1007/s00134-008-1336-9. Epub 2008 Nov 7.</citation>
    <PMID>18989656</PMID>
  </reference>
  <reference>
    <citation>Kowalczyk W, Rybicki Z, Tomaszewski D, Truszczyński A, Guzek A. [The comparison of different bronchial aspirate culturing methods in patients with ventilator-associated pneumonia (VAP)]. Anestezjol Intens Ter. 2011 Apr-Jun;43(2):74-9. Polish.</citation>
    <PMID>22011866</PMID>
  </reference>
  <reference>
    <citation>Butler KL, Best IM, Oster RA, Katon-Benitez I, Lynn Weaver W, Bumpers HL. Is bilateral protected specimen brush sampling necessary for the accurate diagnosis of ventilator-associated pneumonia? J Trauma. 2004 Aug;57(2):316-22.</citation>
    <PMID>15345979</PMID>
  </reference>
  <reference>
    <citation>Gerbeaux P, Ledoray V, Boussuges A, Molenat F, Jean P, Sainty JM. Diagnosis of nosocomial pneumonia in mechanically ventilated patients: repeatability of the bronchoalveolar lavage. Am J Respir Crit Care Med. 1998 Jan;157(1):76-80.</citation>
    <PMID>9445281</PMID>
  </reference>
  <verification_date>January 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 10, 2016</study_first_submitted>
  <study_first_submitted_qc>January 30, 2017</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 1, 2017</study_first_posted>
  <last_update_submitted>January 30, 2017</last_update_submitted>
  <last_update_submitted_qc>January 30, 2017</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 1, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University Hospital Olomouc</investigator_affiliation>
    <investigator_full_name>Radovan Uvizl</investigator_full_name>
    <investigator_title>Radovan Uvízl, MD, PhD</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pneumonia</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

